Results 71 to 80 of about 43,044 (314)

Early applicability of retinopathy of prematurity score (ROPScore) and serum insulin growth factor-1 (IGF-1) for predicting treatment-requiring retinopathy of prematurity: a prospective cohort study

Egyptian Pediatric Association Gazette
Background Retinopathy of prematurity is a leading cause of blindness especially in developing countries where the accessibility to screening may not be available.
Aliaa Adel Ali, Nancy Abd El-Salam Ahmed Gomaa, Basma Samir Kamil, Ahmed Awadein, Heba Baz, Esraa Ahmed Elmazzahy   +5 more
doaj   +1 more source

ORGANIZATION, EXPERIENCE OF OBSERVATION AND TREATMENT OF PREMATURE INFANTS IN THE Fyodorov Eye Microsurgery Federal State Institution of Minzdrav of Russia, Novosibirsk Branch

Сибирский научный медицинский журнал, 2019
Purpose – to analyze the effectiveness of the algorithm used to monitor and treat premature infants. Material and methods. 903 premature babies were under the supervision of ophthalmologists from our clinic over the past 4 years (2014–2017).
K. A. Belousova, D. R. Mamulat, M. A. Sharokhin, I. L. Plisov, N. G. Antsiferova, V. V. Solov'yova   +5 more
doaj   +1 more source

Comparison of the effectiveness of conbercept and ranibizumab treatment for retinopathy of prematurity

Acta ophthalmologica, 2020
To compare the effectiveness of intravitreal conbercept and ranibizumab treatment for retinopathy of prematurity (ROP).
Yong Cheng, Xuemei Zhu, D. Linghu, Jianhong Liang   +3 more
semanticscholar   +1 more source

A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis

Arthritis &Rheumatology, Accepted Article.
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane, Christopher C. Striebich, Marie L. Feser, James R. O'Dell, Judith A. James, Jeffrey A. Sparks, John M. Davis, Jonathan Graf, Maureen A. McMahon, Elizabeth B. Solow, Lindsy Forbess, Athan Tiliakos, Elena Schiopu, Maria I. Danila, Diane L. Horowitz, Jonathan Kay, Colin D. Strickland, Joel M. Guthridge, Cristina Arriens, Jennifer M. Grossman, M. Kristen Demoruelle, Elizabeth A. Bemis, Ashley Frazer‐Abel, Chelsie L. Fleischer, David A. Fox, Ted R. Mikuls, Melissa Greenleaf, Kate York, Sarah Walker, Lynette Keyes‐Elstein, Margie Byron, Janel Fedler, Ellen A. Goldmuntz, V. Michael Holers   +33 more
wiley   +1 more source

Risk factor analysis for the development and progression of retinopathy of prematurity

PLoS ONE, 2019
Purpose To classify the risk factors that contribute to the development versus progression of retinopathy of prematurity (ROP). Methods The medical records of premature infants born with a birth weight (BW) less than 1501 g or a gestational age (GA) of ...
Ji Woong Chang
semanticscholar   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

Anatomical outcome of laser treatment alone in aggressive retinopathy of prematurity

Oman Journal of Ophthalmology
PURPOSE: The purpose is to study the anatomical outcome of eyes in aggressive retinopathy of prematurity (AROP), treated with laser photocoagulation alone and to evaluate factors affecting outcomes.
Anamika Dwivedi, Deepak Dwivedi, Sujata Lakhtakia, Chalisgaonkar Charudutt   +3 more
doaj   +1 more source

The Fovea in Retinopathy of Prematurity

Investigative Ophthalmology and Visual Science, 2020
Purpose Because preterm birth and retinopathy of prematurity (ROP) are associated with poor visual acuity (VA) and altered foveal development, we evaluated relationships among the central retinal photoreceptors, postreceptor retinal neurons, overlying ...
James D. Akula, Ivana A. Arellano, Emily A. Swanson, Tara L. Favazza, Theodore Bowe, R. Munro, R. Ferguson, R. Hansen, A. Moskowitz, A. Fulton   +9 more
semanticscholar   +1 more source

Layered double hydroxides‐based nanozymes for effective biomedical applications: A review and future perspectives

BMEMat, EarlyView.
In this review, we introduced the preparation methods of LDHzymes and discussed their catalytic activity and mechanisms. Subsequently, the applications of LDHzymes in biomedical were discussed. Finally, potential future work on LDHzymes was proposed to better design these new types of nanozymes.
Jiawei Cui, Lu Zhang, Junyi Li, Yue Chen, Sheng Dai, Manfred F. Maitz, Ansha Zhao, Ping Yang   +7 more
wiley   +1 more source

Evaluation of a deep learning image assessment system for detecting severe retinopathy of prematurity

British Journal of Ophthalmology, 2018
Background Prior work has demonstrated the near-perfect accuracy of a deep learning retinal image analysis system for diagnosing plus disease in retinopathy of prematurity (ROP).
Travis K. Redd, J. P. Campbell, James M. Brown, S. Kim, S. Ostmo, R. Chan, Jennifer G. Dy, Deniz Erdoğmuş, Stratis Ioannidis, Jayashree Kalpathy-Cramer, M. Chiang   +10 more
semanticscholar   +1 more source